Healthcare Professionals

• Why KOGENATE^® Bayer?

• Terumo^® Safety Butterfly

• Prophylaxis

• FAQs
• Request medical information

Bayer Links

• Bayer UK/I
• Factor Fitness

• General Conditions of Use
• Privacy Statement
• Imprint

Continuous infusion

Patient information

You can download the following files in PDF format :

Evidence confirms the benefits of continuous infusion with KOGENATE^® Bayer

Background

KOGENATE^® Bayer is licensed for continuous infusion in haemophilia A patients undergoing major surgery.Continuous infusion of factor VIII (FVIII)concentrates – such as KOGENATE^® Bayer- has the following advantages over intermittent bolus injections:

For details on the KOGENATE^® Bayer continuous infusion study please click here

References

18. Mulcahy R et al.Haemophilia 2005;11 (3):208-215.
19. Luboshitz J et al.Hemophilia 2006 World Congress, Vancouver, Canada,May 21-25,2006.

Produced by Bayer. This website is intended for HealthCare professionals.
Date of preparation: December 2010 UK.PH.HN.KOG.2010.250.23.3